Related Experiment Video
Updated: Jun 27, 2026

Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source
Published on: December 23, 2022
Successful use of diltiazem in calcinosis caused by connective tissue disease
T P Torralba1, J Li-Yu, S T Navarra
1Section of Rheumatology and Clinical Immunology, University of Santo Tomas Hospital, Manila 1008, Philippines.
Abstract:
The mechanism for calcinosis in connective tissue disease remains unclear. Various therapies such as warfarin, colchicine, steroids, and bisphosphonates have been tried. However, despite some benefit in early cases, improvement generally is not seen in advanced cases of calcinosis. Several recent studies strongly suggest a favorable response of calcinosis to diltiazem, a calcium channel antagonist. This report concerns two Filipino women, one with dermatomyositis, the other with undifferentiated connective tissue disease, who showed significant reduction of widespread calcinosis after treatment with diltiazem.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Cardiomyopathy II: Dilated Cardiomyopathy
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Action of Calcium Channel Blockers